M A Beydoun1, A Boueiz, M R Shroff, H A Beydoun, Y Wang, A B Zonderman. 1. National Institutes of Health Biomedical Research Center, National Institute on Aging, Intramural Research Program, 251 Bayview Boulevard, Suite 100, Room 04b118, Baltimore, Maryland 21224, USA. baydounm@mail.nih.gov
Abstract
CONTEXT: Recent evidence indicates that a higher plasma level of 25-hydroxyvitamin D [25(OH)D] is associated with lower adiposity and a reduced number of metabolic disturbances (MetD). OBJECTIVES: We examined associations among dietary quality, 25(OH)D, percent body fat (%BF), and MetD, and a pathway linking them, across central obesity. DESIGN: This cross-sectional nationally representative study used extensive data from the National Health and Nutrition Examination Surveys of 2001-2004. PARTICIPANTS: U.S. adults aged at least 20 yr were stratified by central obesity (CO) status. Sample sizes ranged from 1943 (all MetD combined) to 7796 (each component). MAIN OUTCOME MEASURES: %BF was measured using dual-energy x-ray absorptiometry, and MetD was measured with individual continuous nonadiposity outcomes (e.g. fasting plasma glucose) and with a composite count index of binary MetD with prespecified cutoff points (Index I). RESULTS: A higher 25(OH)D was associated with better dietary quality, lower %BF, and lower number of MetD. These inverse 25(OH)D-%BF and 25(OH)D-MetD associations (i.e. fasting blood glucose, homeostatic model assessment of insulin resistance, C-reactive protein, and Index I) were significantly stronger among the CO+ group. Finally, the pathway linking the dairy component of the Healthy Eating Index (HEIdairy) to Index I through 25(OH)D and %BF indicated complete mediation among the CO- group, but HEIdairy and 25(OH)D had direct inverse associations with Index I among the CO+ group. CONCLUSIONS: Due to potential genetic differences between CO- and CO+ groups, empowering U.S. adults with central obesity to make related behavioral changes may be especially effective in improving their vitamin D status and metabolic profile.
CONTEXT: Recent evidence indicates that a higher plasma level of 25-hydroxyvitamin D [25(OH)D] is associated with lower adiposity and a reduced number of metabolic disturbances (MetD). OBJECTIVES: We examined associations among dietary quality, 25(OH)D, percent body fat (%BF), and MetD, and a pathway linking them, across central obesity. DESIGN: This cross-sectional nationally representative study used extensive data from the National Health and Nutrition Examination Surveys of 2001-2004. PARTICIPANTS: U.S. adults aged at least 20 yr were stratified by central obesity (CO) status. Sample sizes ranged from 1943 (all MetD combined) to 7796 (each component). MAIN OUTCOME MEASURES: %BF was measured using dual-energy x-ray absorptiometry, and MetD was measured with individual continuous nonadiposity outcomes (e.g. fasting plasma glucose) and with a composite count index of binary MetD with prespecified cutoff points (Index I). RESULTS: A higher 25(OH)D was associated with better dietary quality, lower %BF, and lower number of MetD. These inverse 25(OH)D-%BF and 25(OH)D-MetD associations (i.e. fasting blood glucose, homeostatic model assessment of insulin resistance, C-reactive protein, and Index I) were significantly stronger among the CO+ group. Finally, the pathway linking the dairy component of the Healthy Eating Index (HEIdairy) to Index I through 25(OH)D and %BF indicated complete mediation among the CO- group, but HEIdairy and 25(OH)D had direct inverse associations with Index I among the CO+ group. CONCLUSIONS: Due to potential genetic differences between CO- and CO+ groups, empowering U.S. adults with central obesity to make related behavioral changes may be especially effective in improving their vitamin D status and metabolic profile.
Authors: Rosemary Bland; Danijela Markovic; Claire E Hills; Susan V Hughes; Susan L F Chan; Paul E Squires; Martin Hewison Journal: J Steroid Biochem Mol Biol Date: 2004-05 Impact factor: 4.292
Authors: Anand Vaidya; Bei Sun; Carol Larson; John P Forman; Jonathan S Williams Journal: J Clin Endocrinol Metab Date: 2012-04-26 Impact factor: 5.958
Authors: May A Beydoun; J Atilio Canas; Hind A Beydoun; Xiaoli Chen; Monal R Shroff; Alan B Zonderman Journal: J Nutr Date: 2012-07-18 Impact factor: 4.798
Authors: Caitlin Mason; Liren Xiao; Ikuyo Imayama; Catherine R Duggan; Carolyn Bain; Karen E Foster-Schubert; Angela Kong; Kristin L Campbell; Ching-Yun Wang; Marian L Neuhouser; Li Li; Robert W Jeffery; Kim Robien; Catherine M Alfano; George L Blackburn; Anne McTiernan Journal: Am J Clin Nutr Date: 2011-05-25 Impact factor: 7.045
Authors: J Mitri; J Nelson; R Ruthazer; C Garganta; D M Nathan; F B Hu; B Dawson-Hughes; A G Pittas Journal: Eur J Clin Nutr Date: 2014-01-22 Impact factor: 4.016
Authors: Patricia M Guenther; Kellie O Casavale; Jill Reedy; Sharon I Kirkpatrick; Hazel A B Hiza; Kevin J Kuczynski; Lisa L Kahle; Susan M Krebs-Smith Journal: J Acad Nutr Diet Date: 2013-02-13 Impact factor: 4.910
Authors: May A Beydoun; Monal R Shroff; Xiaoli Chen; Hind A Beydoun; Youfa Wang; Alan B Zonderman Journal: J Nutr Date: 2011-03-30 Impact factor: 4.798
Authors: Anand Vaidya; John P Forman; Patricia C Underwood; Paul N Hopkins; Gordon H Williams; Luminita H Pojoga; Jonathan S Williams Journal: Eur J Endocrinol Date: 2011-03-14 Impact factor: 6.664
Authors: May A Beydoun; Marie T Fanelli-Kuczmarski; Hind A Beydoun; Greg A Dore; Jose A Canas; Michele K Evans; Alan B Zonderman Journal: Br J Nutr Date: 2018-03 Impact factor: 3.718